Sterile Fill Finish
Collaborative Partnership in Sterile Injectable Drug Manufacturing
We understand the value of providing partners with a full-service model. Using our integrated approach to tech transfer and highly cultivated process capabilities, we can collaborate with partners to deliver quality products, time and time again. Whether your project is in the early clinical stages or requires large-scale commercial supply, our comprehensive suite of services can meet the diverse needs of sterile injectable projects.
From Large to Small Batch, We Fill It All
Our facilities enable us to aseptically fill and terminally sterilize your products on a commercial-sized scale, ensuring precision and quality at every step. JHS project management provides integrated solutions that seamlessly combine sterile dosage liquid and lyo manufacturing and packaging under one roof. This streamlined approach eliminates unnecessary complexities and guarantees a smooth project transition.
Clinical Trial Manufacturing
Our Spokane facility is equipped to complete your next clinic trial, sterile fill finish project with scalability, efficiency, and control.
New! Spokane Facility Line 3 Features
Complete your next fill finish project on our newly qualified line. This addition is equipped with:
- Full isolator technology
- Single-use compounding and filling technologies
- 100% weight checking of every vial at production speeds
- Three compounding suites with capacity for up to 2000 L bulks
Two Facilities to Meet Your Manufacturing Needs
| Capabilities | Spokane Facility | Montreal Facility |
|---|---|---|
| Vial Accommodation | 2 mL – 100 mL | 2 mL – 40 mL |
| Batch Capacity | 20 – 2,000 L | Up to 350 L |
| Lines | Three filling lines, with a fourth coming online in 2026. | One filling line, with a second coming online in 2027. |
Stay Up to Date with JHS
Sterile injectable manufacturing requires much more than available capacity and equipment. This critical stage of the drug manufacturing process, when outsourced, calls for a contract manufacturing organization (CMO) that can prove its value in key areas.
Jubilant HollisterStier, a wholly owned subsidiary of ultimate parent company Jubilant Pharmova Limited, announces $92M investment to expand sterile injectable manufacturing capacity at its site in Spokane, WA.
Begin the Manufacturing Process Now
Contact us today to partner with JHS on your next manufacturing project.